
#200: Insulin and QWINT-1 Trial in T2DM: Beyond Journal Club Segment with NEJM Group
From metformin to basal insulin to overlooked older medications, this episode reviews the T2D medication toolkit clinicians use every day. We then dive into new evidence on once-weekly insulin to help you individualize therapy while reducing treatment burden. 🔹 Sponsor: Pain Management and Opioids Adaptive Learning Free Online Course by NEJM Group: https://cme-info.nejm.org/core-im/ 🔹Transcript and Shownotes: 00.58 | Insulin Hx & Types 06:00 | Indications for Insulin and the Burden on Patients 08:26 | What is the QWINT-1 Trial? 16:18 | Discussion Tags: CoreIM, Internal Medicine, Evidence-Based Medicine, Insulin Resistance, Clinical Reasoning, Hospital Medicine, Medical Education, Endocrine, Endocrinology Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840 Our Sponsors: * Check out Eko: https://ekohealth.com * Check out ElevenReader and use my code PODCAST for a great deal: https://elevenreader.io * Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com
Publisher
Core IM | Internal Medicine Podcast
Link
www.coreimpodcast.com/2026/02/11/insulin-and-qwint-1-trial/
Published
February 11, 2026
Duration
28 min
Format
Podcast
Category
Lifestyle · Medicine
Source
RSS feed
Host
Core IM Team
Core IM | Internal Medicine Podcast
@coreiminternalmedicinepodcas
#insulin #journalclubsegment #nejmgroup #medicine #mentalhealth
